“INTERLEUKIN-40 AS A PREDICTIVE TOOL OF RESPONSE TO TREATMENT FOR INSULIN RESISTANCE IN PATIENTS WITH TYPE 2 DIABETES”. CAHIERS MAGELLANES-NS, vol. 6, no. 2, Aug. 2024, pp. 3635-42, http://cahiersmagellanes.com/index.php/CMN/article/view/633.